Total Payments
$1.6M
2024 Payments
$275,172
Companies
19
Transactions
1,725
Payment Breakdown by Category
Other$927,852 (58.0%)
Consulting$422,663 (26.4%)
Travel$184,882 (11.5%)
Research$34,161 (2.1%)
Food & Beverage$31,169 (1.9%)
Education$15.92 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $914,996 | 353 | 57.2% |
| Consulting Fee | $422,663 | 114 | 26.4% |
| Travel and Lodging | $184,882 | 818 | 11.5% |
| Unspecified | $34,161 | 14 | 2.1% |
| Food and Beverage | $31,169 | 418 | 1.9% |
| Honoraria | $12,856 | 7 | 0.8% |
| Education | $15.92 | 1 | 0.0% |
Payments by Type
General
$1.6M
1,711 transactions
Research
$34,161
14 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1.5M | 1,599 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $30,886 | 47 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $15,400 | 10 | $0 (2021) |
| Radius Health, Inc. | $10,967 | 23 | $0 (2024) |
| Kyowa Kirin, Inc. | $9,237 | 16 | $0 (2024) |
| UCB SA | $6,758 | 4 | $0 (2024) |
| Novo Nordisk Inc | $6,000 | 2 | $0 (2023) |
| PFIZER INC. | $4,000 | 2 | $0 (2024) |
| ABBVIE INC. | $2,724 | 7 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $2,085 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $275,172 | 295 | Amgen Inc. ($256,417) |
| 2023 | $188,653 | 271 | Amgen Inc. ($159,375) |
| 2022 | $123,558 | 155 | Amgen Inc. ($122,781) |
| 2021 | $112,319 | 64 | Amgen Inc. ($103,512) |
| 2020 | $116,514 | 113 | Amgen Inc. ($108,814) |
| 2019 | $362,978 | 368 | Amgen Inc. ($360,390) |
| 2018 | $240,438 | 247 | Amgen Inc. ($221,767) |
| 2017 | $181,112 | 212 | Amgen Inc. ($176,883) |
All Payment Transactions
1,725 individual payment records from CMS Open Payments — Page 1 of 69
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | EVENITY (Biological) | Consulting Fee | Cash or cash equivalent | $1,490.00 | General |
| Category: Bone Health | ||||||
| 12/18/2024 | Amgen Inc. | EVENITY (Biological) | — | In-kind items and services | $10,627.05 | Research |
| Study: Ph3 PMO Fracture Study ALN SupVert • Category: Bone Health | ||||||
| 12/13/2024 | Amgen Inc. | Prolia (Biological) | Consulting Fee | Cash or cash equivalent | $3,352.50 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,335.00 | General |
| Category: Bone Health | ||||||
| 11/16/2024 | Amgen Inc. | EVENITY (Biological) | Consulting Fee | Cash or cash equivalent | $8,567.50 | General |
| Category: Bone Health | ||||||
| 11/08/2024 | UCB SA | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 11/07/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $176.29 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | Cash or cash equivalent | $41.83 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $20.77 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $11.17 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,868.00 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,868.00 | General |
| Category: Bone Health | ||||||
| 10/31/2024 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| 10/28/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 10/25/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,364.00 | General |
| Category: Bone Health | ||||||
| 10/25/2024 | Amgen Inc. | Prolia (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,364.00 | General |
| Category: Bone Health | ||||||
| 10/25/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $115.52 | General |
| 10/21/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $280.32 | General |
| Category: Bone Health | ||||||
| 10/21/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | Cash or cash equivalent | $70.26 | General |
| Category: Bone Health | ||||||
| 10/21/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $65.55 | General |
| Category: Bone Health | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Ph3 PMO Fracture Study ALN SupVert | Amgen Inc. | $10,627 | 1 |
| Ph3 PMO Fracture Study Placebo | Amgen Inc. | $4,445 | 1 |
| A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF BMS-986036 (PEG-FGF21) IN ADULTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) AND COMPENSATED LIVER CIRRHOSIS | E.R. Squibb & Sons, L.L.C. | $3,850 | 3 |
| A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF BMS-986036 (PEG-FGF21) IN ADULTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) AND STAGE 3 LIVER FIBROSIS | E.R. Squibb & Sons, L.L.C. | $3,850 | 3 |
| P4 Analysis of Romo TBS in FREEDOM | Amgen Inc. | $3,500 | 1 |
| Phase IIB Study F3 24 wk | E.R. Squibb & Sons, L.L.C. | $3,500 | 1 |
| A PHASE 2B RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF BMS 986036 PEG FGF21 IN ADULTS WITH NONALCOHOLIC STEATOHEPATITIS NASH AND COMPENSATED LIVER CIRRHOSIS | E.R. Squibb & Sons, L.L.C. | $1,750 | 1 |
| A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF BMS-986036 PEG-FGF21 IN ADULTS WITH NONALCOHOLIC STEATOHEPATITIS NASH AND COMPENSATED LIVER CIRRHOSIS | E.R. Squibb & Sons, L.L.C. | $1,225 | 1 |
| A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF BMS-986036 PEG-FGF21 IN ADULTS WITH NONALCOHOLIC STEATOHEPATITIS NASH AND STAGE 3 LIVER FIBROSIS | E.R. Squibb & Sons, L.L.C. | $1,225 | 1 |
| Impact of Site of Care on Osteoporosis Treatment and Outcomes | Amgen Inc. | $189.07 | 1 |
About Dr. Michael Mcclung, M.D
Dr. Michael Mcclung, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477580207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mcclung, M.D has received a total of $1.6M in payments from pharmaceutical and medical device companies, with $275,172 received in 2024. These payments were reported across 1,725 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($914,996).
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Portland, OR
- Active Since 06/27/2006
- Last Updated 10/18/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477580207
Products in Payments
- Prolia (Biological) $691,141
- EVENITY (Biological) $689,755
- XGEVA (Biological) $9,535
- Crysvita (Drug) $9,073
- Enbrel (Biological) $7,713
- Tymlos (Biological) $7,095
- Strensiq (Drug) $4,998
- Tymlos (Drug) $3,623
- IMLYGIC (Biological) $2,000
- STRENSIQ (Biological) $834.24
- ELIGARD (Drug) $500.00
- NEXPLANON (Drug) $332.00
- Veozah (Drug) $250.00
- MyoSure manual (Device) $114.31
- ANNOVERA (Drug) $110.66
- Myosure Manual (Device) $80.00
- NO PRODUCT DISCUSSED (Drug) $62.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Portland
James Neifing, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $475,019
Endocrinology, Diabetes & Metabolism $475,019
Maria Fleseriu, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $418,716
Endocrinology, Diabetes & Metabolism $418,716
Rodica Busui, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $211,479
Endocrinology, Diabetes & Metabolism $211,479
Jonathan Purnell, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $209,631
Endocrinology, Diabetes & Metabolism $209,631
Nancy Curosh, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $194,307
Endocrinology, Diabetes & Metabolism $194,307
Andrew Ahmann, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $109,693
Endocrinology, Diabetes & Metabolism $109,693